Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jun;71(6):832-43.
doi: 10.1111/j.1365-2125.2011.03923.x.

Slow-release oral morphine for opioid maintenance treatment: a systematic review

Affiliations

Slow-release oral morphine for opioid maintenance treatment: a systematic review

Jeremie Jegu et al. Br J Clin Pharmacol. 2011 Jun.

Abstract

This review article summarizes the results of all available clinical trials considering the use of slow-release oral morphine (SROM) for opioid maintenance treatment (OMT). All studies published up to October 2010 and assessing SROM for OMT in adult patients are included. Three independent reviewers assessed the selected articles using a standardized checklist. Study design, study length and number of subjects included were recorded. Data about retention rate (proportion of participants remaining under maintenance treatment at the end of the study), quality of life, withdrawal symptoms, craving, additional drug consumption, driving capacity and adverse events were collected. We identified 13 articles corresponding to nine clinical trials considering the use of SROM for OMT. Among them, only one was a randomized trial and one was a controlled not randomized trial. All other studies were uncontrolled. Retention rates were good (from 80.6 to 95%) with SROM maintenance, but similar retention rates were obtained with methadone. Most of the studies showed that quality of life, withdrawal symptoms, craving and additional drug consumption improved with SROM. However, there was no comparison with other maintenance drugs. As most of the studies assessing SROM efficacy were uncontrolled, there is no definite evidence that SROM is an effective alternative to methadone for OMT.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram of number of studies screened, assessed for eligibility and included. SROM, slow-release oral morphine

References

    1. United Nations Office on Drugs and Crime. World Drug Report 2009. United Nations Publication, 2009. Available at http://www.unodc.org/unodc/en/data-and-analysis/WDR-2009.html.
    1. O'Brien CP. Overview: the treatment of drug dependence. Addiction. 1994;89:1565–9. - PubMed
    1. European Monitoring Centre for Drugs and Drug Addiction. Macro-Economic Analysis of Heroin Markets in the EU and the Impact of Substitution Treatment. Lisbon: European Monitoring Centre for Drugs and Drug Addiction; 2000. Available at http://www.emcdda.europa.eu/html.cfm/index67936EN.html.
    1. Lavignasse P, Lowenstein W, Batel P, Constant MV, Jourdain JJ, Kopp P, Reynaud-Maurupt C, Riff B, Videau B, Mucchielli A. Economic and social effects of high-dose buprenorphine substitution therapy. Six-month results. Ann Med Interne (Paris) 2002;153:1S20–6. - PubMed
    1. Gronbladh L, Ohlund LS, Gunne LM. Mortality in heroin addiction: impact of methadone treatment. Acta Psychiatr Scand. 1990;82:223–7. - PubMed

Publication types

MeSH terms